These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26319548)

  • 61. Fitting complex population models by combining particle filters with Markov chain Monte Carlo.
    Knape J; de Valpine P
    Ecology; 2012 Feb; 93(2):256-63. PubMed ID: 22624307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Flexible Bayesian quantile regression for independent and clustered data.
    Reich BJ; Bondell HD; Wang HJ
    Biostatistics; 2010 Apr; 11(2):337-52. PubMed ID: 19948746
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bayesian semiparametric modeling for matched case-control studies with multiple disease states.
    Sinha S; Mukherjee B; Ghosh M
    Biometrics; 2004 Mar; 60(1):41-9. PubMed ID: 15032772
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development of uncertainty-based work injury model using Bayesian structural equation modelling.
    Chatterjee S
    Int J Inj Contr Saf Promot; 2014; 21(4):318-27. PubMed ID: 24111548
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lifting a veil on diversity: a Bayesian approach to fitting relative-abundance models.
    Golicher DJ; O'Hara RB; Ruíz-Montoya L; Cayuela L
    Ecol Appl; 2006 Feb; 16(1):202-12. PubMed ID: 16705973
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data.
    Wendling T; Tsamandouras N; Dumitras S; Pigeolet E; Ogungbenro K; Aarons L
    AAPS J; 2016 Jan; 18(1):196-209. PubMed ID: 26538125
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bayesian modeling of the level and duration of fertility in the menstrual cycle.
    Dunson DB
    Biometrics; 2001 Dec; 57(4):1067-73. PubMed ID: 11764245
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Bayesian multi-dimensional couple-based latent risk model with an application to infertility.
    Hwang BS; Chen Z; M Buck Louis G; Albert PS
    Biometrics; 2019 Mar; 75(1):315-325. PubMed ID: 30267541
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Projecting the future burden of cancer: Bayesian age-period-cohort analysis with integrated nested Laplace approximations.
    Riebler A; Held L
    Biom J; 2017 May; 59(3):531-549. PubMed ID: 28139001
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of paediatric visual acuity using Bayesian copula models with sinh-arcsinh marginal densities.
    Stander J; Dalla Valle L; Taglioni C; Liseo B; Wade A; Cortina-Borja M
    Stat Med; 2019 Aug; 38(18):3421-3443. PubMed ID: 31144351
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The hierarchical Bayesian approach to population pharmacokinetic modelling.
    Smith A; Wakefield J
    Int J Biomed Comput; 1994 Jun; 36(1-2):35-42. PubMed ID: 7927858
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bayesian population physiologically-based pharmacokinetic model for robustness evaluation of withdrawal time in tilapia aquaculture administrated to florfenicol.
    Lin HC; Chen WY
    Ecotoxicol Environ Saf; 2021 Mar; 210():111867. PubMed ID: 33387907
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bayesian analysis of coupled cellular and nuclear trajectories for cell migration.
    Chakraborty S; Lan T; Tseng Y; Wong SWK
    Biometrics; 2022 Sep; 78(3):1209-1220. PubMed ID: 33813733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Bayesian model for classifying all differentially expressed proteins simultaneously in 2D PAGE gels.
    Wu SH; Black MA; North RA; Rodrigo AG
    BMC Bioinformatics; 2012 Jun; 13():137. PubMed ID: 22712439
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Many hepatitis C reinfections that spontaneously clear may be undetected: Markov-chain Monte Carlo analysis of observational study data.
    Sacks-Davis R; McBryde E; Grebely J; Hellard M; Vickerman P
    J R Soc Interface; 2015 Mar; 12(104):20141197. PubMed ID: 25589564
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bayesian variable selection in the accelerated failure time model with an application to the surveillance, epidemiology, and end results breast cancer data.
    Zhang Z; Sinha S; Maiti T; Shipp E
    Stat Methods Med Res; 2018 Apr; 27(4):971-990. PubMed ID: 28034170
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A hierarchical Bayesian approach to calibrating the linear-quadratic model from clonogenic survival assay data.
    Collis J; Hill MR; Nicol JR; Paine PJ; Coulter JA
    Radiother Oncol; 2017 Sep; 124(3):541-546. PubMed ID: 28870637
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bayesian calibration of a natural history model with application to a population model for colorectal cancer.
    Whyte S; Walsh C; Chilcott J
    Med Decis Making; 2011; 31(4):625-41. PubMed ID: 21127321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bayesian change-point modeling with segmented ARMA model.
    Sadia F; Boyd S; Keith JM
    PLoS One; 2018; 13(12):e0208927. PubMed ID: 30596668
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Spatio-temporal interaction with disease mapping.
    Sun D; Tsutakawa RK; Kim H; He Z
    Stat Med; 2000 Aug; 19(15):2015-35. PubMed ID: 10900449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.